Capital Markets – Hong Kong Public Offerings

 

• In terms of Red Chips listing, Mr. Li has successfully advised the listing of Gaush Meditech Ltd, Zibuyu Group Limited, Howkingtech International Holding Limited, GUSHENGTANG HOLDINGS LIMITED, Chaoju Eye Care Holdings Limited, Hygeia Healthcare Holdings Co., Limited, Simcere Pharmaceutical Group Limited, Strawbear Entertainment Group, Neusoft Education Technology Co. Limited, Netjoy Holdings Limited, Jinxin Fertility Group Limited, Ascletis Pharma Inc., New Century Healthcare Holding Co. Limited, Harmonicare Medical Holdings Limited, MicroPort Scientific Corporation, Weimob Inc., Midea Real Estate Holding Limited, DaFa Properties Group Limited, Optics Valley Union Holding Company Limited, Zhou Hei Ya International Holdings Company Limited, Yihai International Holding Ltd., Yadea Group Holdings Ltd., Honma Golf Limited, Koradior Holdings Limited, China Agri-Industries Holdings Limited, Tenwow International Holdings Limited, China Yongda Automobiles Services Holdings Limited, Fosun Tourism Group, China Huirong Financial Holdings Limited, Chinalco Mining Corporation International, Dameng Mining Industries Ltd. and China Resources Cement Holdings Limited.
• In terms of H Share listing, Mr. Li has successfully advised the listing of CanSino Biologics Inc., Chanjet Information Technology Company Limited, Livzon Pharmaceutical Group Inc., Bank of Gansu Co., Ltd., Bank of Tianjin Co., Ltd., Zhongyuan Bank Co., Ltd., Holly Futures Co., Ltd., Guangzhou Automobile Group Co., Ltd., China International Marine Containers (Group) Co., Ltd., China Coal Holdings Limited, Huadian Fuxin Energy Corporation Limited, Metallurgical Corporation of China Ltd., China Communications Construction Company Limited and China Coal Energy Company Limited.

 

M&A and Private Equity Investment

 

• Represented Hygeia Healthcare Holdings Co., Limited in its RMB1.73 billion acquisition of the entire equity interest in Etern Group Ltd.
• Represented Hygeia Healthcare Holdings Co., Limited in its up to RMB642 million acquisition of 99% equity interest in Hezhou Guangji Hospital Co., Ltd. from GF Xinde (Zhuhai) Medical Industrial Investment Center L.P.
• Represented Beijing Chuangxinzhong Technology Co., Ltd. in the acquisition of its 42.5% equity interest by YEAHKA LIMITED.
• Represented OrbiMed in its subscription of convertible bond and warrant issued by Union Medical Healthcare Limited.
• Represented the management of Xiamen Qinhuai Technology Co., Ltd. along with Bain Capital in the management buy-out of Qinhuai Data and its subsidiaries and the merger of Qinhuai Data and Bridge Data Center in 2019 (the single largest IDC investment in China so far).
• Represented China Ocean Shipping (Group) Company and China COSCO Shipping Corporation Limited in the landmark restructuring, comprising a series of asset acquisitions and disposals among its patent companies and its subsidiaries. The restructuring represents a substantial reconfiguration of two of China’s leading state-owned enterprises which, on a combined basis, will become the world’s fourth largest container-shipping company. This transaction was awarded “Deal of the Year 2016” by Asia Business Law Journal.
• Represented Taikang Insurance Group in its acquisition of a 26.44% stake in Harmonicare Medical Holdings Limited, a Hong Kong-listed the largest private obstetrics and gynecology specialty hospital group based in China.
• Represented SCPG Holdings Co., Ltd., a leading shopping mall owner, developer, and operator in China, China Vanke Co., Ltd., a leading urban and rural construction and residential service provider, and Triwater Asset Management Holdings Limited, in the formation of an offshore consortium for the purpose of acquiring a large-scale Chinese real estate portfolio from CapitaLand Mall Asia Limited, a wholly owned subsidiary of CapitaLand Limited, for RMB8.365 billion. The portfolio comprises of 20 shopping malls, with a total gross floor area of around 950,000 square meters, in locations across 19 cities in China.
• Represented Strawbear Entertainment Group in its Pre-IPO investment in Taurus Holding Ltd., a subsidiary of iQIYI, with a total value of RMB270 million.

• Represented Green Tea Restaurant, a leading Chinese casual dining restaurant chain, in its financing from Partners Group, one of the world’s largest private equity investment companies.
• Represented Ally Bridge Group, in its Series B investment into LinkDoc Technology Limited, a leading oncology big data company based in China, alongside other leading Chinese and international investors.
• Represented HOPU Investment, in its formation of a strategic partnership with COFCO Meat, one of the largest hog producers in China, as one of the investors. HOPU Investments is a China-focused private equity firm with an international investment platform that has a focus on the consumer, natural resources, and financial services industries. The investor consortium also included KKR, Baring Private Equity Asia and Boyu Capital, which will invest in COFCO Meat alongside its existing shareholders to build and manage large-scale industrialized hog farms and meat processing plants in China.
• Represented China Huarong Asset Management Co., Ltd. in its US$2.4 billion capital increase from a consortium of strategic investors, including China Life Insurance, Warburg Pincus, CITIC Securities International, Khazanah Nasional Berhad, China International Capital Corporation, COFCO, Fosun International and Goldman Sachs.
• Represented Digitalis Capital in its Series B round investment in Mollybox.
• Represented Guangzhou Auto, the fourth largest auto group in China, in its privatization of Denway Motors, a Hong Kong listed company. This transaction was awarded “M&A Deal of the Year 2011” by China Law & Practice, and “Best Domestic M&A Deal 2011” by FinanceAsia.
• Represented Gorgeous Investments Limited in its US$172 million acquisition of 51.72% of share capital of China Smarter Energy Group Holdings Limited, a Hong Kong listed company, and tendering mandatory unconditional cash offer to acquire all issued shares.
• Represented Massive Force Limited in its mandatory unconditional cash offer and acquire 74.10% issued shares in KFM Kingdom Holdings Limited.
• Represented Nat-Ace Pharmaceutical in its US$35 million acquisition of 52.79% of the entire share capital of Perception Digital Holdings Limited. Pursuant to the Hong Kong Takeovers Code, CCB International Capital Limited for and on behalf of Nat-Ace Pharmaceutical has made an unconditional mandatory cash offer to acquire all the issued shares in and cancel all outstanding options of Perception Digital.
• Represented Junfun Investment Limited, in its US$4,936,000 acquisition of 58.71% of the entire share capital of Grand Concord International Holdings Limited and tendering general offer to other shareholders.
• Represented CDH Investment as the subscriber in the issuance of HK$300 million convertible bond by China Grand Pharmaceutical and Healthcare Holdings Limited, a Hong Kong listed company, and represented CDH Investment, in the US$25 million acquisition of up to 20% interest in Shanghai Weicon Optical Co. Ltd.
• Represented New Lion Bridge Co., Ltd in the issuance of US$160 million guaranteed senior notes, guaranteed by its sole shareholders, Lionbridge Capital. Guotai Junan International, UBS, ICBC International and Zhongtai International were the underwriters.